Abstract:Intron removal from premature-mRNA (pre-mRNA splicing) is an essential part of gene expression and regulation that is required for the production of mature, protein-coding mRNA. The spliceosome (SPL), a majestic machine composed of five small nuclear RNAs and hundreds of proteins, behaves as an eminent transcriptome tailor, efficiently performing splicing as a protein-directed metallo-ribozyme. To select and excise long and diverse intronic sequences with single-nucleotide precision, the SPL undergoes a continuous compositional and conformational remodeling, forming eight distinct complexes throughout each splicing cycle. Splicing fidelity is of paramount importance to preserve the integrity of the proteome. Mutations in splicing factors can severely compromise the accuracy of this machinery, leading to aberrant splicing and altered gene expression. Decades of biochemical and genetic studies have provided insights into the SPL's composition and function, but its complexity and plasticity have prevented an in-depth mechanistic understanding. Single-particle cryogenic electron microscopy techniques have ushered in a new era for comprehending eukaryotic gene regulation, providing several near-atomic resolution structures of the SPL from yeast and humans. Nevertheless, these structures represent isolated snapshots of the splicing process and are insufficient to exhaustively assess the function of each SPL component and to unravel particular facets of the splicing mechanism in a dynamic environment.In this Account, building upon our contributions in this field, we discuss the role of biomolecular simulations in uncovering the mechanistic intricacies of eukaryotic splicing in health and disease. Specifically, we showcase previous applications to illustrate the role of atomic-level simulations in elucidating the function of specific proteins involved in the architectural reorganization of the SPL along the splicing cycle. Moreover, molecular dynamics applications have uniquely contributed to decrypting the channels of communication required for critical functional transitions of the SPL assemblies. They have also shed light on the role of carcinogenic mutations in the faithful selection of key intronic regions and the molecular mechanism of splicing modulators. Additionally, we emphasize the role of quantum-classical molecular dynamics in unraveling the chemical details of pre-mRNA cleavage in the SPL and in its evolutionary ancestors, group II intron ribozymes. We discuss methodological pitfalls of multiscale calculations currently used to dissect the splicing mechanism, presenting future challenges in this field. The results highlight how atomic-level simulations can enrich the interpretation of experimental results. We envision that the synergy between computational and experimental approaches will aid in developing innovative therapeutic strategies and revolutionary gene modulation tools to fight the over 200 human diseases associated with splicing misregulation, including cancer and neurodegeneration.

Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions

Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors

Atomic-Level Mechanism of Pre-mRNA Splicing in Health and Disease

Alternative pre-mRNA splicing in stem cell function and therapeutic potential: A critical review of current evidence

RNA mis-splicing in disease

Roles and mechanisms of alternative splicing in cancer — implications for care

Therapeutic strategies for aberrant splicing in cancer and genetic disorders

Transcriptome-wide splicing network reveals specialized regulatory functions of the core spliceosome

Genomics of alternative splicing: evolution, development and pathophysiology

Research Progresses of Regulation of Alternative Splicing

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer

RNA structure in alternative splicing regulation: from mechanism to therapy

Dysregulation and therapeutic targeting of RNA splicing in cancer

From computational models of the splicing code to regulatory mechanisms and therapeutic implications

RNA Structures in Alternative Splicing and Back‐splicing

Targeting RNA-Splicing for SMA Treatment

Splicing mutations in human genetic disorders: examples, detection, and confirmation

Therapeutic potential of alternative splicing in cardiovascular diseases

Conservation and Regulation of Alternative Splicing by Dynamic Inter- and Intra-Intron Base Pairings in Lepidoptera 14-3-3z Pre-Mrnas